E907 5
Generic Name: oxymorphone
Pill imprint E907 5 has been identified as Opana ER 5 mg.
Opana ER is used in the treatment of pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy.
Opana ER 5 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.
Opana ER Images
- Generic Name:
- oxymorphone
- Imprint:
-
E907 5
- Strength:
- 5 mg
- Color:
- Pink
- Size:
- 8.00 mm
- Shape:
- Eight-sided
- Availability:
- Prescription only
- Inactive Ingredients:
- hypromellose
ferric oxide black
methylparaben
propylene glycol
silicified microcrystalline cellulose
sodium stearyl fumarate
TIMERx-N
titanium dioxide
triacetin
polysorbate 80
ferric oxide red
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Endo Pharmaceuticals Inc.
- National Drug Code (NDC):
- 63481-0907
Advertisement
More Opana ER resources
- Opana ER Extended-Release Tablets (Wolters Kluwer)
- Opana ER (Cerner Multum)
- Opana ER (Micromedex) - Includes Dosage Information
- Opana ER (FDA)
Search Again
